| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-320 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-323 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-324 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18645025 | |
| miR-328 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-32 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-320 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-326 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 19883630 | |
| miR-324 | Doxorubicin (Adriamycin) | small cell lung cancer | Sensitive | High | 20371173 | |
| miR-329 | Doxorubicin (Adriamycin) | small cell lung cancer | Sensitive | High | 20371173 | |
| miR-32 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-323 | Doxorubicin (Adriamycin) | chronic myelogenous leukemia | Sensitive | High | 24303078 | |
| miR-320a | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 25159093 | |
| miR-320d | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 25562151 | |
| miR-326 | Doxorubicin (Adriamycin) | liver cancer | Sensitive | High | 25698578 | |
| miR-326 | Doxorubicin (Adriamycin) | hepatocellular carcinoma | Sensitive | Low | 25714665 |